122 related articles for article (PubMed ID: 25417213)
1. Genetic deletion of Wdr13 improves the metabolic phenotype of Lepr (db/db) mice by modulating AP1 and PPARĪ³ target genes.
Singh VP; Gurunathan C; Singh S; Singh B; Lakshmi BJ; Mishra AP; Kumar S
Diabetologia; 2015 Feb; 58(2):384-92. PubMed ID: 25417213
[TBL] [Abstract][Full Text] [Related]
2. Wdr13 and streptozotocin-induced diabetes.
Mishra AP; Yedella K; Lakshmi JB; Siva AB
Nutr Diabetes; 2018 Oct; 8(1):57. PubMed ID: 30369599
[TBL] [Abstract][Full Text] [Related]
3. Restoration of
D'souza AM; Kieffer TJ
Mol Metab; 2017 Jun; 6(6):585-593. PubMed ID: 28580288
[TBL] [Abstract][Full Text] [Related]
4. Impaired liver regeneration and lipid homeostasis in CCl
Mishra AP; Siva AB; Gurunathan C; Komala Y; Lakshmi BJ
Lab Anim Res; 2020 Nov; 36(1):41. PubMed ID: 33292732
[TBL] [Abstract][Full Text] [Related]
5. WD-repeat protein WDR13 is a novel transcriptional regulator of c-Jun and modulates intestinal homeostasis in mice.
Singh VP; Katta S; Kumar S
BMC Cancer; 2017 Feb; 17(1):148. PubMed ID: 28222755
[TBL] [Abstract][Full Text] [Related]
6. Lack of Wdr13 gene in mice leads to enhanced pancreatic beta cell proliferation, hyperinsulinemia and mild obesity.
Singh VP; Lakshmi BJ; Singh S; Shah V; Goel S; Sarathi DP; Kumar S
PLoS One; 2012; 7(6):e38685. PubMed ID: 22715406
[TBL] [Abstract][Full Text] [Related]
7. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes.
de Luca C; Kowalski TJ; Zhang Y; Elmquist JK; Lee C; Kilimann MW; Ludwig T; Liu SM; Chua SC
J Clin Invest; 2005 Dec; 115(12):3484-93. PubMed ID: 16284652
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation.
Marino JS; Iler J; Dowling AR; Chua S; Bruning JC; Coppari R; Hill JW
PLoS One; 2012; 7(10):e48643. PubMed ID: 23119079
[TBL] [Abstract][Full Text] [Related]
9. Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome.
Wang MY; Grayburn P; Chen S; Ravazzola M; Orci L; Unger RH
Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6139-44. PubMed ID: 18413598
[TBL] [Abstract][Full Text] [Related]
10. Transgenic complementation of leptin receptor deficiency. II. Increased leptin receptor transgene dose effects on obesity/diabetes and fertility/lactation in lepr-db/db mice.
Chua SC; Liu SM; Li Q; Sun A; DeNino WF; Heymsfield SB; Guo XE
Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E384-92. PubMed ID: 14600075
[TBL] [Abstract][Full Text] [Related]
11. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.
Park SY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Hong KW
J Pharmacol Exp Ther; 2009 May; 329(2):571-9. PubMed ID: 19221061
[TBL] [Abstract][Full Text] [Related]
12. Preadipocyte transplantation: an in vivo study of direct leptin signaling on adipocyte morphogenesis and cell size.
Guo K; Mogen J; Struzzi S; Zhang Y
Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1339-47. PubMed ID: 19193947
[TBL] [Abstract][Full Text] [Related]
13. Transgenic expression of a mutated cyclin-dependent kinase 4 (CDK4/R24C) in pancreatic beta-cells prevents progression of diabetes in db/db mice.
Miyawaki K; Inoue H; Keshavarz P; Mizuta K; Sato A; Sakamoto Y; Moritani M; Kunika K; Tanahashi T; Itakura M
Diabetes Res Clin Pract; 2008 Oct; 82(1):33-41. PubMed ID: 18678431
[TBL] [Abstract][Full Text] [Related]
14. Rescue of cardiac leptin receptors in db/db mice prevents myocardial triglyceride accumulation.
Hall ME; Maready MW; Hall JE; Stec DE
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E316-25. PubMed ID: 24939734
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated interference of FABP4 regulates mRNA expression of ADIPOQ, LEP and LEPR in bovine adipocytes.
Wei S; Zan LS; Wang HB; Cheng G; Du M; Jiang Z; Hausman GJ; McFarland DC; Dodson MV
Genet Mol Res; 2013 Feb; 12(1):494-505. PubMed ID: 23315880
[TBL] [Abstract][Full Text] [Related]
16. New leptin receptor mutations in mice: Lepr(db-rtnd), Lepr(db-dmpg) and Lepr(db-rlpy).
Kim JH; Taylor PN; Young D; Karst SY; Nishina PM; Naggert JK
J Nutr; 2003 May; 133(5):1265-71. PubMed ID: 12730408
[TBL] [Abstract][Full Text] [Related]
17. Leptin receptor-induced STAT3-independent signaling pathways are protective against atherosclerosis in a murine model of obesity and hyperlipidemia.
Luo W; Bodary PF; Shen Y; Wickenheiser KJ; Ohman MK; Guo C; Bahrou KL; Myers MG; Eitzman DT
Atherosclerosis; 2011 Jan; 214(1):81-5. PubMed ID: 21067751
[TBL] [Abstract][Full Text] [Related]
18. Pro-inflammatory Macrophages suppress PPARĪ³ activity in Adipocytes via S-nitrosylation.
Yin R; Fang L; Li Y; Xue P; Li Y; Guan Y; Chang Y; Chen C; Wang N
Free Radic Biol Med; 2015 Dec; 89():895-905. PubMed ID: 26475041
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological blockade of the EP3 prostaglandin E
Bosma KJ; Andrei SR; Katz LS; Smith AA; Dunn JC; Ricciardi VF; Ramirez MA; Baumel-Alterzon S; Pace WA; Carroll DT; Overway EM; Wolf EM; Kimple ME; Sheng Q; Scott DK; Breyer RM; Gannon M
Mol Metab; 2021 Dec; 54():101347. PubMed ID: 34626853
[TBL] [Abstract][Full Text] [Related]
20. Extreme obesity induces massive beta cell expansion in mice through self-renewal and does not alter the beta cell lineage.
Cox AR; Lam CJ; Rankin MM; King KA; Chen P; Martinez R; Li C; Kushner JA
Diabetologia; 2016 Jun; 59(6):1231-41. PubMed ID: 27003683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
